Keyvan Fallah-Mehrjardi

Keyvan Fallah currently works at the Department of Immunology, Tehran University of Medical Sciences. He has studied the new approach of cancer immunotherapy, CAR T cell therapy, especially tumor microenvironment modulation to mitigate some harsh properties of this environment to improve CAR T cell efficacy in Dr. Hadjati lab. He is also working on a project for the National Elite Foundation to serve in the military.

Living in : Iran

Gender : MaleRace : Middle Eastern

0Followers 0Following

Academic Profile

Posts

Contact Information

-Email

KeyvanFallah-MehrjardiApplyChance Link

Educations

Cancer Immunology And ImmunotherapyMaster'sTehran University of Medical Sciences2019-11-25 Iran

Title :

Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitro

Microbiology, Cell And Molecular BiologyBachelor'sUniversity of Isfahan2016-07-11 Iran

Work Experiences

laboratory

at tehranteb laboratory

Start : 24-Apr-2021

End : 20-Dec-2022

Journal Publications

Publication Title :

Construction and functional characterization of a fully human anti-CD19 chimeric antigen receptor (huCAR)-expressing primary human T cellsCorresponding author

Journal :

Journal of Cellular Physiology

Link :

View Link

Publication Title :

Nanoparticle-siRNA: A potential strategy for Ovarian Cancer Therapy? Second author

Journal :

Nanomedicine

Link :

View Link

Publication Title :

Pharmacological targeting of immune checkpoint A2aR improves function of anti-CD19 CAR T cells in vitroFirst author

Journal :

Immunology Letters

Link :

View Link

Publication Title :

Construction and functional characterization of fullyhuman anti-mesothelin chimeric antigen receptor (CAR)-expressing T cells in vitroCorresponding author

Journal :

Iranian Journal of Allergy, Asthma and Immunology

Link :

View Link

Publication Title :

Prolonged persistence of chimeric antigen receptor (CAR) T cells in adoptive cancer immunotherapy: challenges and ways forwardThird author

Journal :

Frontiers in Immunology

Link :

View Link

Publication Title :

A metabolic switch to memory CART cells: Implications for cancer treatmentSecond author

Journal :

Cancer Letters

Link :

View Link

Publication Title :

Genetics and pharmacological targeting of A2a receptor improves function of anti-mesothelin CAR T cellCorresponding author

Journal :

Journal of Experimental and Clinical Cancer Research

Link :

View Link

Publication Title :

Targeted knockdown of Tim3 by short hairpin RNAs improves the function of anti-mesothelin CAR T cellsCorresponding author

Journal :

Molecular Immunology

Link :

View Link

Publication Title :

Mitochondria as Playmakers of CAR T-cell Fate and LongevityThird author

Journal :

Cancer Immunology Research

Link :

View Link

Publication Title :

Restricting tumor lactate metabolism using dichloroacetate improves T cell functionsCorresponding author

Journal :

BMC Cancer

Link :

View Link

Publication Title :

MicroRNA-124 Enhances T Cells Functions by Manipulating the Lactic Acid Metabolism of Tumor CellsCorresponding author

Journal :

Iranian Journal of Allergy, Asthma and Immunology

Link :

View Link

Awards

First Rank Student in UniversityMaster

ranked 1entrance exam2019-11-13

References

jamshid hadjati

hajatij@tums.ac.ir

farshid noorbaksh

f-noorbakhsh@tums.ac.ir

hamidreza mirzaei

hamidmirzaei81@gmail.com